The agency wants applicants to demystify their algorithms and provide specific details about what the models do, how they’re ...
Three Georgia companies and their principals have been banned from continuing their "bogus claims" that their stem cell ...
U.S. government report on “notorious markets” known for counterfeiting and other violations of intellectual property says ...
The government is changing what foods can be branded as “healthy.” It expects basically no one to listen.
Click in for more news from The Hill{beacon} Health Care Health Care The Big Story Washington state tries new way to ...
The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...
The FDA has granted priority review to a Biologics License Application for nipocalimab to treat individuals with generalized ...
Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.
FDA's Patrizia Cavazzoni to retire as CDER chief in 2nd senior official's departure in span of weeks
The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire ...
The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...
On second thought, the FDA figures it no longer needs to discuss Exelixis’ application for Cabometyx in neuroendocrine tumors ...
D Molecular Therapeutics reaches agreement with FDA for phase 3 trial design of DME candidate 4D-150, showing promising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback